Business Description
Hyphens Pharma International Ltd
ISIN : SG1EE4000006
Share Class Description:
SGX:1J5: Ordinary SharesCompare
Compare
Traded in other countries / regions
1J5.Singapore IPO Date
2018-05-18Description
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.32 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.33 | |||||
| Interest Coverage | 36.15 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.03 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.5 | |||||
| 3-Year EBITDA Growth Rate | 18.1 | |||||
| 3-Year EPS without NRI Growth Rate | 18.2 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | 15.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.79 | |||||
| 9-Day RSI | 53.57 | |||||
| 14-Day RSI | 50.76 | |||||
| 6-1 Month Momentum % | -3.64 | |||||
| 12-1 Month Momentum % | -20.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | |||||
| Quick Ratio | 1.62 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 82.86 | |||||
| Days Sales Outstanding | 71.53 | |||||
| Days Payable | 128.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.11 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| 3-Year Dividend Growth Rate | 5.3 | |||||
| Forward Dividend Yield % | 3.19 | |||||
| 5-Year Yield-on-Cost % | 4.11 | |||||
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 6.07 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.22 | |||||
| Operating Margin % | 7.56 | |||||
| Net Margin % | 5.6 | |||||
| FCF Margin % | 5.79 | |||||
| ROE % | 13.02 | |||||
| ROA % | 7.86 | |||||
| ROIC % | 23.06 | |||||
| ROC (Joel Greenblatt) % | 54.54 | |||||
| ROCE % | 15.34 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.48 | |||||
| PE Ratio without NRI | 9.48 | |||||
| Price-to-Owner-Earnings | 5.63 | |||||
| PEG Ratio | 0.76 | |||||
| PS Ratio | 0.55 | |||||
| PB Ratio | 1.23 | |||||
| Price-to-Tangible-Book | 1.72 | |||||
| Price-to-Free-Cash-Flow | 9.48 | |||||
| Price-to-Operating-Cash-Flow | 7.85 | |||||
| EV-to-EBIT | 5.14 | |||||
| EV-to-EBITDA | 4.12 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-Forward-Revenue | 0.56 | |||||
| EV-to-FCF | 6.07 | |||||
| Price-to-Projected-FCF | 0.63 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.59 | |||||
| Price-to-Graham-Number | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 1.96 | |||||
| Earnings Yield (Greenblatt) % | 19.45 | |||||
| FCF Yield % | 10.64 | |||||
| Forward Rate of Return (Yacktman) % | 20.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hyphens Pharma International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil S$) | 156.323 | ||
| EPS (TTM) (S$) | 0.029 | ||
| Beta | 0.04 | ||
| Volatility % | 20.53 | ||
| 14-Day RSI | 50.76 | ||
| 14-Day ATR (S$) | 0.003786 | ||
| 20-Day SMA (S$) | 0.27275 | ||
| 12-1 Month Momentum % | -20.9 | ||
| 52-Week Range (S$) | 0.265 - 0.345 | ||
| Shares Outstanding (Mil) | 309.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hyphens Pharma International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hyphens Pharma International Ltd Stock Events
| Event | Date | Price(S$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hyphens Pharma International Ltd Frequently Asked Questions
What is Hyphens Pharma International Ltd(SGX:1J5)'s stock price today?
The current price of SGX:1J5 is S$0.28. The 52 week high of SGX:1J5 is S$0.35 and 52 week low is S$0.27.
When is next earnings date of Hyphens Pharma International Ltd(SGX:1J5)?
The next earnings date of Hyphens Pharma International Ltd(SGX:1J5) is .
Does Hyphens Pharma International Ltd(SGX:1J5) pay dividends? If so, how much?
The Dividend Yield %  of Hyphens Pharma International Ltd(SGX:1J5) is 4.11% (As of Today), Highest Dividend Payout Ratio of Hyphens Pharma International Ltd(SGX:1J5) was 0.39. The lowest was 0.18. And the median was 0.25. The  Forward Dividend Yield % of Hyphens Pharma International Ltd(SGX:1J5) is 3.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers